High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine.
作者信息
Dimou Maria, Roumelioti Maria, Dimitrakopoulou Aglaia, Bitsani Catherin, Kotsanti Sotiria, Petsa Panayiota, Papaioannou Paraskevi, Kyrtsonis Marie-Christine, Panayiotidis Panayiotis
机构信息
a First Propedeutic Department of Internal Medicine, Hematology Unit , National and Kapodistrian University of Athens, Laikon General Hospital , Athens , Greece.
b Department of Immunology and Histocompatibility , Laiko Geniko Nosokomeio , Athens , Greece.
出版信息
Leuk Lymphoma. 2018 May;59(5):1264-1267. doi: 10.1080/10428194.2017.1375108. Epub 2017 Sep 13.
Abstract
摘要
相似文献
1
High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine.
Leuk Lymphoma. 2018 May;59(5):1264-1267. doi: 10.1080/10428194.2017.1375108. Epub 2017 Sep 13.
2
Recurrence of abdominal large-vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5-azacytidine in a patient with myelodysplastic syndrome.
Eur J Haematol. 2014 Apr;92(4):362-4. doi: 10.1111/ejh.12249. Epub 2014 Jan 10.
3
Azacitidine-induced acute lung injury in a patient with therapy-related myelodysplastic syndrome.
J Int Med Res. 2017 Apr;45(2):886-893. doi: 10.1177/0300060517698331. Epub 2017 Mar 16.
4
Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome.
Br J Haematol. 2015 May;169(4):461. doi: 10.1111/bjh.13341. Epub 2015 Mar 12.
5
Hypomethylating therapy and autoimmunity in MDS: an enigmatic relationship.
Leuk Res. 2012 Apr;36(4):e90-2. doi: 10.1016/j.leukres.2011.12.013. Epub 2012 Jan 9.
6
Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes.
Leuk Res. 2012 Jul;36(7):e146-8. doi: 10.1016/j.leukres.2012.03.007. Epub 2012 Apr 5.
7
Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.
Eur J Haematol. 2017 Aug;99(2):112-118. doi: 10.1111/ejh.12883. Epub 2017 Apr 20.
8
Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment.
Ann Hematol. 2013 Nov;92(11):1577-9. doi: 10.1007/s00277-013-1748-7. Epub 2013 Apr 13.
9
5-Azacytidine for the treatment of myelodysplastic syndromes.
Expert Opin Pharmacother. 2013 Jun;14(9):1255-68. doi: 10.1517/14656566.2013.794222. Epub 2013 Apr 27.
10
Necrotizing fasciitis in two patients with myelodysplastic syndrome treated with azacitidine.
Eur J Haematol. 2015 Mar;94(3):273-6. doi: 10.1111/ejh.12365. Epub 2014 May 17.
Zotero 插件